102 related articles for article (PubMed ID: 1768503)
21. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis.
Jones PH
Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769
[No Abstract] [Full Text] [Related]
22. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
Moriarty P; Sosland R; Gibson C; Belmont J
Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
[TBL] [Abstract][Full Text] [Related]
23. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
[TBL] [Abstract][Full Text] [Related]
24. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis.
Murashima J; Ueki Y; Matsunaga Y; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):725-32. PubMed ID: 9890715
[TBL] [Abstract][Full Text] [Related]
25. Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis.
Pintus S; Pintus P; Piras C; Loviselli A; Muntoni S
J Clin Apher; 1994; 9(2):124-5. PubMed ID: 7798159
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal circuit heparinization in selective low density lipoprotein apheresis: changes in patient hemostasis and low molecular weight heparin benefit.
Lorenzini JL; Dutrillaux F; Mousson C; Lassale B; Maynadié M; Rifle G
J Clin Apher; 1993; 8(3):141-6. PubMed ID: 8300550
[TBL] [Abstract][Full Text] [Related]
27. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
[TBL] [Abstract][Full Text] [Related]
28. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption--a case report.
Koenig W; Ditschuneit HH; Hehr R; Grunewald RW; Ernst E; Hombach V
Angiology; 1992 Jul; 43(7):606-9. PubMed ID: 1626740
[TBL] [Abstract][Full Text] [Related]
29. Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol--the role of LDL-apheresis.
McGowan MP
J Clin Lipidol; 2013; 7(3 Suppl):S21-6. PubMed ID: 23642325
[TBL] [Abstract][Full Text] [Related]
30. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
[TBL] [Abstract][Full Text] [Related]
31. Selective and semiselective low-density lipoprotein apheresis in familial hypercholesterolemia.
Busnach G; Cappelleri A; Vaccarino V; Franceschini G; Dal Col A; Perrino ML; Brando B; Sirtori C; Minetti L
Blood Purif; 1988; 6(3):156-61. PubMed ID: 3395475
[TBL] [Abstract][Full Text] [Related]
32. In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation.
Grützmacher P; Landgraf H; Esser R; Okon J; Vlachojannis J; Ehrly AM; Schoeppe W
ASAIO Trans; 1990; 36(3):M327-30. PubMed ID: 2252691
[TBL] [Abstract][Full Text] [Related]
33. [Extracorporeal methods for low-density lipoprotein apheresis in treating patients with severe forms of hereditary hypercholesterolemia. A review].
Konovalov GA
Ter Arkh; 1991; 63(10):111-9. PubMed ID: 1805407
[No Abstract] [Full Text] [Related]
34. Effects of losartan on low-density lipoprotein apheresis.
Kojima S; Yoshitomi Y; Saotome M; Tanaka K; Shida M; Kuramochi M
Ther Apher; 1999 Nov; 3(4):303-6. PubMed ID: 10608722
[TBL] [Abstract][Full Text] [Related]
35. Isolation of lipoprotein (a) using the regenerate of a dextran sulfate cellulose LDL apheresis system.
Gross E; März W; Siekmeier R; Scharrer I; Gross W
Protein Expr Purif; 1994 Apr; 5(2):112-7. PubMed ID: 8054842
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of plasmapheresis, cascade-filtration and dextran-sulfate adsorption apheresis with calculation of the recovery rate of lipids and lipoproteins.
Schwartzkopff W; Nold A; Gräfenhahn H; von Baeyer H; Schwerdtfeger R
Beitr Infusionsther; 1988; 23():103-11. PubMed ID: 2484763
[No Abstract] [Full Text] [Related]
37. Lipid apheresis, indications, and principles.
Winters JL
J Clin Apher; 2011; 26(5):269-75. PubMed ID: 21834078
[TBL] [Abstract][Full Text] [Related]
38. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems.
Jovin IS; Taborski U; Stehr A; Müller-Berghaus G
Metabolism; 2000 Nov; 49(11):1431-3. PubMed ID: 11092506
[TBL] [Abstract][Full Text] [Related]
39. Some aspects of the use of dextran sulfate-cellulose columns for the treatment of familial hypercholesterolemia.
Erlich D; Aubert I; Neel D; Scrobohaci ML; Loreau J; Bussel A; Rouffy J; Dreux C; Goussault Y; Weintraub H
Clin Chim Acta; 1991 Sep; 201(3):169-74. PubMed ID: 1756589
[No Abstract] [Full Text] [Related]
40. Anaphylactoid-like reactions in a patient with HyperLp(a)lipidemia undergoing LDL apheresis with dextran sulfate adsorption and herbal therapy with the spice turmeric.
Adamski J; Jamensky L; Ross J; Siegel DL; Sachais BS
J Clin Apher; 2010; 25(6):354-7. PubMed ID: 20806416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
